Switch to:
More From Other Websites
Hanesbrands, AstraZeneca Plop into Wednesday’s 52-Week Low Club Dec 07 2016
Can AstraZeneca Plc (AZN) Lung Cancer Pill Take Over Chemo Treatment? Dec 07 2016
Top Research Reports for Cisco, Merck & MasterCard Dec 07 2016
AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting Dec 07 2016
AstraZeneca PLC (ADR) (AZN) Relocating Jobs At U.K. Division Dec 06 2016
AstraZeneca Reports Positive Lung Cancer Drug Trial Results Dec 06 2016
TAGRISSO® (osimertinib) Demonstrates Superiority over Chemotherapy in EGFR T790M Mutation-Positive... Dec 06 2016
5:03 am AstraZeneca reports Phase III trial of Tagrisso; demonstrates superiority over chemotherapy Dec 06 2016
AstraZeneca pill slashes lung cancer progression in study Dec 06 2016
AstraZeneca pill slashes lung cancer progression in study Dec 06 2016
4 dividend stocks to put on your 2017 shopping list Dec 06 2016
FitBit, Teva Slide into Monday’s 52-Week Low Club Dec 05 2016
Is Diageo plc (ADR) (DEO) A Good Stock To Buy? Dec 05 2016
Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat Chronic Lymphocytic... Dec 05 2016
Is ReNeuron Group plc a better buy than AstraZeneca plc? Dec 05 2016
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda Dec 02 2016
Is Celgene Corporation (CELG) Worthy of Your Portfolio? Dec 01 2016
AstraZeneca in broad drug deal with Bicycle worth up to $1 billion Dec 01 2016
AstraZeneca in broad drug deal with Bicycle worth up to $1 bln Dec 01 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK